 - Patients must have inadequate diabetes control as defined by glycosylated hemoglobin greater than or equal to 7.0 to less than or equal to 10.5 at screening and be either 1 not currently on diabetes drug therapy or 2 on therapy with any approved class of diabetes drugs 